Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-4_04-cv-05429/USCOURTS-cand-4_04-cv-05429-2/pdf.json

Nature of Suit Code: 830
Nature of Suit: Patent
Cause of Action: 35:271 Patent Infringement

---

M CDERMOTT 

WILL 

& EMERY LLP

ATTORNEYS AT LA W

PALO ALTO

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

MPK 92461-8.073241.0011 STIPULATED PROTECTIVE ORDER

CASE NO. 04-CV-05429 CW

MCDERMOTT WILL & EMERY LLP

WILLIAM G. GAEDE, III (136184)

wgaede@mwe.com

ANDREW A. KUMAMOTO (178541)

akumamoto@mwe.com

3150 Porter Drive

Palo Alto, CA 94304-1212

Telephone: (650) 813-5000

Facsimile: (650) 813-5100

Attorneys for Tercica, Inc.

HELLER EHRMAN LLP

M. PATRICIA THAYER (90818)

patricia.thayer@hellerehrman.com

ETHAN C. GLASS (216159)

ethan.glass@hellerehrman.com

333 Bush Street

San Francisco, CA 94104-2878

Telephone: (415) 772-6794

Facsimile: (415) 772-6268

Attorneys for Genentech, Inc

FOLEY & LARDNER LLP

E. PATRICK ELLISEN, BAR NO. 142033

pellisen@foley.com

DAVID B. MOYER, BAR NO. 197739

dmoyer@foley.com

1530 Page Mill Road

Palo Alto, CA 94304

Telephone: 650.251.1114

Facsimile: 650.856.3710

FOLEY & LARDNER LLP

LARRY L. SHATZER, PRO HAC VICE

lshatzer@foley.com

GEORGE C. BEST, PRO HAC VICE

gbest@foley.com

LIANE M. PETERSON, PRO HAC VICE

lpeterson@foley.com

3000 K ST., N.W.

Washington, DC 20007

Telephone: 202.672.5300

Facsimile: 202.672.5399

Attorneys for Defendants, INSMED INCORPORATED and 

CELTRIX PHARMACEUTICALS,INC.

Case 4:04-cv-05429-CW Document 169 Filed 09/07/05 Page 1 of 22
M CDERMOTT 

WILL 

& EMERY LLP

ATTORNEYS AT LA W

PALO ALTO

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

MPK 92461-8.073241.0011 2

STIPULATED PROTECTIVE ORDER

CASE NO. 04-CV-05429 CW

UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF CALIFORNIA

GENENTECH, INC., a Delaware 

Corporation, TERCICA, INC., a Delaware 

Corporation,

Plaintiffs,

v.

INSMED INCORPORATED, a Virginia 

Corporation, CELTRIX 

PHARMACEUTICALS, INC., a Delaware 

corporation,

Defendants.

No. 04-CV-05429-CW

STIPULATED PROTECTIVE ORDER

This matter, having been brought before the Court by GENENTECH, INC., a Delaware 

Corporation (“GENENTECH”), TERCICA, INC., a Delaware Corporation (“TERCICA”), 

INSMED INCORPORATED, a Virginia Corporation (“INSMED”), and CELTRIX 

PHARMACEUTICALS, INC., a Delaware corporation (“CELTRIX”) (collectively the “Parties”) 

by and through their attorneys of record, for a protective order that access to any materials which 

are the subject of or relate to “Confidential Information,” as defined below, and which are 

disclosed during the course of this action, as defined below, shall be restricted according to the 

terms and conditions of this Stipulation and Protective Order.

TERMS AND CONDITIONS

1. Designation Of Confidential Information.

a. The term “Confidential Information” is anything that qualifies for protection under 

Federal Rules of Civil Procedure 26(c), including without limitation, trade secrets as defined 

under California Civil Code § 3426.1(d), the Virginia Uniform Trade Secrets Act, or applicable 

case law, as well as other information which in the ordinary course is neither made available to 

the general public nor the industry at large and to which access is restricted and efforts have been 

made to keep the information from being broadly disseminated such as technical, research, or 

Case 4:04-cv-05429-CW Document 169 Filed 09/07/05 Page 2 of 22
M CDERMOTT 

WILL 

& EMERY LLP

ATTORNEYS AT LA W

PALO ALTO

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

MPK 92461-8.073241.0011 3

STIPULATED PROTECTIVE ORDER

CASE NO. 04-CV-05429 CW

development information, commercial, financial, budgeting and/or accounting information, 

information about existing and potential customers, patient information, marketing studies, 

performance, and projections, business strategies, decisions and/or negotiations, personnel 

compensation, evaluations and other employment information, and/or confidential and proprietary 

information about affiliates, parents, subsidiaries and third parties with whom the Parties to this 

action have had business relationships. The term “Confidential Information” also includes,

without limitation, pending applications to and communications with governmental and 

regulatory authorities such as the Patent and Trademark Office and the Food and Drug 

Administration and their foreign counterparts.

b. The scope of this Stipulation shall be understood to encompass not only those 

items or things which are expressly designated as Confidential Information, but also any 

information derived therefrom, and all documents, copies, excerpts, and summaries containing 

Confidential Information, as well as testimony and oral communications containing Confidential 

Information or information derived therefrom.

c. Any party to this action, or third party who has received a subpoena for production 

of documents, may designate documents, information and things as “Confidential Information.” 

Such party is hereby referred to as the “Designating Party.”

d. In designating Confidential Information, the Designating Party may designate 

discovery material as “CONFIDENTIAL” only if that party believes, reasonably and in good 

faith, that information contained therein satisfies the definition set forth in paragraph 1(a).

e. The designation of Confidential Information shall be made at the following time: 

(1) for documents, at the time of the production of the documents; (2) for written responses to 

interrogatories or requests for admissions, at the time of the written response; (3) for declarations 

and pleadings, at the time they are filed; (4) for deposition testimony, at the time of the testimony 

or within ten (10) business days after receipt by the Designating Party of the transcript of the 

deposition; and (5) for inspection of things or entry upon land or other property, prior to, or at the 

time of, the inspection or entry.

Case 4:04-cv-05429-CW Document 169 Filed 09/07/05 Page 3 of 22
M CDERMOTT 

WILL 

& EMERY LLP

ATTORNEYS AT LA W

PALO ALTO

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

MPK 92461-8.073241.0011 4

STIPULATED PROTECTIVE ORDER

CASE NO. 04-CV-05429 CW

f. The designation of Confidential Information shall be made in the following 

manner: (1) for documents, by placing the appropriate legend (“CONFIDENTIAL”) on each 

page of such document; (2) for tangible objects, by placing the appropriate legend on the object or 

the container therefore, or if not practicable, as otherwise agreed; (3) for written responses to 

written interrogatories or requests for admissions, by placing the appropriate legend in the 

relevant responses and on the face of any such responses; (4) for declarations or pleadings, by 

placing the appropriate legend on the face or title page of the document; (5) for depositions, orally 

on the record during the deposition, and/or in writing if such designation is made within ten (10) 

business days from the Parties receipt of the transcript; and (6) for inspection of things or entry 

upon land or other property, by stating in writing at or prior to the inspection or entry that 

“CONFIDENTIAL” information will be disclosed by the inspection or entry and specifying in 

writing those parts of the things or those areas of the premises in which such information will be 

revealed. A party producing information from its own files for inspection and selection for 

copying through its counsel may require that during the course of production such documents 

may only be reviewed by qualified persons under paragraph 5 of this Stipulation and Protective 

Order.

g. It shall be the duty of the party seeking protection of Confidential Information to 

indicate to the other party and its attorney of record which of the materials and testimony are 

considered “CONFIDENTIAL.”

h. Each party retains the right to subsequently redesignate documents and to require 

such documents to be treated in accord with such designations from that time forward.

2. Patient information.

a. All Parties agree that patient medical charts and records obtained from the 

patient’s doctor and/or hospital shall be treated as Confidential Information.

b. All Parties agree that Personal Patient Information is not required to be produced. 

To the extent such information is produced by a Party or third party, all Parties shall undertake 

their best efforts to protect such Personal Patient Information, including redacting such 

information from any filing or other disclosure.

Case 4:04-cv-05429-CW Document 169 Filed 09/07/05 Page 4 of 22
M CDERMOTT 

WILL 

& EMERY LLP

ATTORNEYS AT LA W

PALO ALTO

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

MPK 92461-8.073241.0011 5

STIPULATED PROTECTIVE ORDER

CASE NO. 04-CV-05429 CW

c. “Personal Patient Information” shall be interpreted to mean a patient’s full name 

(but not their initials), social security number, address, phone number, fax number, e-mail 

addresses, vehicle numbers, internet addresses, photographs, credit card numbers, birth dates, 

and/or any information that would allow members of the public to discover the identity of the 

patient (except for initials).

3. Resolution Of Disputes Regarding Designation Of Confidential Information.

a. In the event that any party takes issue with a designation of Confidential 

Information, such party shall so inform the other parties to this lawsuit in writing, and all parties 

shall make good faith efforts to meet and confer to resolve such dispute prior to the filing of any 

motion or other request for court intervention.

b. In the event that the parties are unable to resolve the dispute regarding designation 

of Confidential Information within 15 business days from the date the written notice of the 

dispute was mailed, the party disputing the designation may, by noticed motion, raise such issue 

with the Court. The Designating Party shall bear the burden of establishing that the information 

is Confidential Information.

c. A challenge to the propriety of a confidential designation may be made at any 

time.

4. Inadvertent Failure to Designate.

Any party or third party who inadvertently fails to designate information as Confidential 

Information, or otherwise wishes to change the designation of confidentiality under this 

Stipulation and Protective Order, may later do so, and such document/information shall be treated 

by all other Parties as being so designated with confidentiality from the time of the notification in 

writing of the inadvertent designation. A Party shall correct its failure to mark an item as 

Confidential Information in writing accompanied by substitute copies of each item, container or 

folder, appropriately marked “Confidential” pursuant to this Stipulation and Protective Order. 

The parties agree that the inadvertent disclosure of Confidential Information by the Designating 

Party in producing discovery, regardless of whether the information was designated as 

Confidential Information at the time of disclosure, shall not be treated as a waiver in whole or in 

Case 4:04-cv-05429-CW Document 169 Filed 09/07/05 Page 5 of 22
M CDERMOTT 

WILL 

& EMERY LLP

ATTORNEYS AT LA W

PALO ALTO

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

MPK 92461-8.073241.0011 6

STIPULATED PROTECTIVE ORDER

CASE NO. 04-CV-05429 CW

part of a Designating Party’s claim of confidentiality, either as to the specific information 

disclosed or as to any other information relating thereto or on the same or related subject and each 

Party agrees to make reasonable efforts to preserve the confidentiality of the inadvertently 

disclosed information.

5. Access To Confidential Information.

Access to documents marked “CONFIDENTIAL” shall be limited to, and only to, the 

following “Qualified Persons”:

a. “Outside counsel” (attorneys of record as representing any party in connection 

with this action, and their employees and staff), as long as such person is informed of the 

existence and contents of this Stipulation and Protective Order before such person is permitted 

access to any of the information or documents marked “CONFIDENTIAL.” 

b. The following in-house legal staff only shall have access to Confidential 

Information relating to the subject matter described in sections i. – iv. below, as long as such 

person is informed of the existence and contents of this Stipulation and Protective Order before 

such person is permitted access to any of the information or documents marked 

“CONFIDENTIAL”:

from Tercica:

Richard Love, Esq.

from Genentech:

Gary Loeb, Esq.

Hannah Yuen, Esq.

Dan Sherman, Patent Agent-Scientific Advisor

Eddie Wiitala (paralegal)

i. the sections of Insmed’s NDA, and any amendments thereto, identified in 

Attachment B to this Order;

ii. preclinical and clinical trials relating to IGF-I, IGFBP-3, and/or any IGFI/IGFBP-3 combination performed by or for Insmed or its successors, or by or for any other third 

party to the extent that Insmed is permitted to disclose that information;

Case 4:04-cv-05429-CW Document 169 Filed 09/07/05 Page 6 of 22
M CDERMOTT 

WILL 

& EMERY LLP

ATTORNEYS AT LA W

PALO ALTO

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

MPK 92461-8.073241.0011 7

STIPULATED PROTECTIVE ORDER

CASE NO. 04-CV-05429 CW

iii. the manufacturing process used or intended to be used to supply Insmed 

with IGF-I, IGFBP-3, and/or any IGF-I/IGFBP-3 combination, including the manufacturing 

process used by Avecia and the process to be used at Insmed’s Boulder, CO, facility;

iv. the opinions of defendants’ expert witnesses relating to the issues of 

infringement or validity of the asserted patents, and any materials cited or relied upon by such 

experts.

At the time of their production, Insmed shall identify all documents marked 

“Confidential” that it determines in good faith are within categories ii. and iii. The parties will 

meet and confer in an attempt to resolve any dispute about the identification of documents and 

information within categories ii. and iii. If the parties are unable to resolve any such dispute 

informally, Tercica may bring a motion for a determination by the Court that the disputed 

documents or information are within categories ii. and iii. 

The parties reserve the right to seek access by in-house persons to Confidential 

Information not encompassed within this section on a case-by-case basis. In such a case, the 

party seeking access or exclusion must meet and confer with the other parties first, before 

involving the Court, and the parties agree to consider such requests in good faith.

c. Organizations or persons retained by Outside Counsel to provide litigation support 

services in this action. Before any such person is permitted access to any of the Confidential 

Information, such person shall be informed of the existence and contents of this Stipulation and 

Protective Order. Examples of such consultants include jury trial consultants, graphic artists and 

document processing, coding and copying services.

d. Independent scientific and technical experts and consultants retained in this action 

by Outside Counsel, in so far as Outside Counsel may deem it necessary for the preparation or 

trial of this case to consult with such experts or consultants, provided that any such actual or 

contemplated expert or consultant is not a current employee or current or prospective consultant 

of any of the parties hereto, and is not a current employee of their respective counsel; and that any 

such actual or contemplated expert or consultant complies with the requirements of paragraph 6 

of this Stipulation and Protective Order.

Case 4:04-cv-05429-CW Document 169 Filed 09/07/05 Page 7 of 22
M CDERMOTT 

WILL 

& EMERY LLP

ATTORNEYS AT LA W

PALO ALTO

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

MPK 92461-8.073241.0011 8

STIPULATED PROTECTIVE ORDER

CASE NO. 04-CV-05429 CW

e. Mock jurors engaged by any consultant in preparation for trial, excluding, 

however, individuals who are officers, directors, or employees of a named party, or are owners of 

more than a two percent interest in a named party. Any such person shall first agree in writing to 

be bound by this Stipulation and Protective Order, and such agreement shall be retained under 

counsel’s control until final termination of this action.

f. Such other person as hereafter may be designated by written agreement in this 

action or by order of the Court.

g. The Court and those employed by the Court.

6. Disclosure To Experts.

a. Each independent expert and consultant referred to in paragraph 5(d) of this 

Stipulation and Protective Order to whom Confidential Information is to be given, shown, 

disclosed, made available or communicated in any way, shall first execute an affidavit, in 

substantially the form attached hereto as Attachment A, agreeing to be bound by the terms of this 

Stipulation and Protective Order.

b. At least ten (10) business days prior to a party giving, showing, disclosing, making 

available or communicating Confidential Information to any expert or consultant, the party hiring 

such expert or consultant shall deliver to all other parties a copy of the affidavit signed by the 

person to whom Confidential Information is proposed to be disclosed and a description setting 

forth the person’s (i) name, (ii) office address, (iii) present employer, (iv) a brief job history for 

the past ten years; and (v) copy of the experts’ up-to-date and current curriculum vitae.

c. Any other party shall be entitled to object to such disclosure to the expert or 

consultant within seven (7) calendar days after service of the affidavit by stating specifically in 

writing the reasons why that party believes such person should not receive Confidential 

Information.

d. In the event of such an objection, no disclosure of Confidential Information shall 

be made to the expert or consultant for a period of seven (7) calendar days following the date of 

service of the objection, in order to permit the objecting party to move for an order that disclosure 

not be made to such expert or consultant, or made only under certain conditions. The objecting 

Case 4:04-cv-05429-CW Document 169 Filed 09/07/05 Page 8 of 22
M CDERMOTT 

WILL 

& EMERY LLP

ATTORNEYS AT LA W

PALO ALTO

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

MPK 92461-8.073241.0011 9

STIPULATED PROTECTIVE ORDER

CASE NO. 04-CV-05429 CW

party shall have the burden of establishing grounds for barring the disclosure. The objecting

party shall seek to have any such motion set for the earliest possible date on the Court’s motion 

calendar, and shall not be continued without the consent of all parties. If no such motion is made 

in such time and manner, Confidential Information may be disclosed to such expert or consultant 

for the purposes and upon the conditions herein stated. If such a motion is made, there shall be no 

disclosure to such expert or consultant until the Court has ruled upon the motion, and then only in 

accordance with the ruling so made. The filing and pendency of such motion shall not limit, 

delay or defer any disclosures of the Confidential Information to persons as to whom no such 

objection has been made, nor shall it delay or defer any other pending discovery unless the level 

of confidentiality bears directly on the objecting party’s ability to conduct such discovery.

7. Maintenance of Confidential Information By In-House Counsel.

Any Confidential Information designated and produced by another party that is in the 

possession of in-house legal staff of Tercica or Genentech shall be maintained in a secure location 

to which only the individuals specifically designated in this Order shall have access.

8. Use Of Confidential Information Generally.

a. Confidential Information disclosed pursuant to this Stipulation and Protective 

Order shall be used only for purposes of this action and shall be protected from any unauthorized 

or unrelated use.

b. Confidential Information shall be held in confidence by each person to whom it is 

disclosed, shall be used solely in preparation for, and in, ex parte applications, noticed motions, 

the conduct of discovery, preparing for and conducting the trial of this action only, and any post 

trial or appeals, and shall not be used in any patent prosecution, regulatory work, or any business 

or other purpose whatsoever, or in any other litigation, and shall not be disclosed to anyone 

except as provided herein.

c. All the parties to this Stipulation and Protective Order will take all reasonable 

steps to insure tha t Personal Patient Information will be protected from disclosure to ensure the 

patient’s privacy rights.

Case 4:04-cv-05429-CW Document 169 Filed 09/07/05 Page 9 of 22
M CDERMOTT 

WILL 

& EMERY LLP

ATTORNEYS AT LA W

PALO ALTO

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

MPK 92461-8.073241.0011 10 STIPULATED PROTECTIVE ORDER

CASE NO. 04-CV-05429 CW

9. Use Of Confidential Information In Conduct Of This Action.

a. Confidential Information may be used by Outside Counsel in good faith in 

conducting discovery, provided that the Confidential Information is protected pursuant to the 

terms and conditions of this Stipulation and Protective Order.

b. Confidential Information may be disclosed to a witness not already allowed access 

to such information under this Stipulation and Protective Order only if: (a) the Confidential 

Information was previously received or authored by the witness or was authored or received by a 

director, officer, employee or agent of the entity for which the witness is testifying as a Rule 

30(b)(6) designee; (b) the Designating Party is the witness or is a party for whom the witness is at 

the time of disclosure a director, officer, employee, consultant or agent; or, (c) Outside Counsel 

for the party designating the material as Confidential Information agrees that the material may be 

disclosed to the witness.

c. If the Confidential Information is used in any deposition, then, at the option of the 

disclosing party, that portion of the proceeding shall be conducted outside the presence of all 

unqualified persons and any testimony or transcript relating thereto shall be designated as 

Confidential. In the event of disclosure under this paragraph, only the reporter, deponent, his/her 

counsel, and persons to whom disclosure may be made, and who are bound by this Stipulation 

and Protective Order, may be present during the disclosure or discussion of Confidential 

Information. Disclosure of material pursuant to this paragraph shall not constitute a waiver of 

confidential status of the material so disclosed.

d. Notwithstanding the parties’ designation of Confidential Information, any court 

hearing which refers to or describes Confidential Information shall in the Court’s discretion be 

held in open court with records unsealed unless there is a specific showing under law that 

confidentiality is required. The disclosing party has the option to request that the proceeding 

shall be conducted in camera, out of the presence of all unqualified persons and any transcript 

relating thereto shall be designated as confidential.

Case 4:04-cv-05429-CW Document 169 Filed 09/07/05 Page 10 of 22
M CDERMOTT 

WILL 

& EMERY LLP

ATTORNEYS AT LA W

PALO ALTO

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

MPK 92461-8.073241.0011 11 STIPULATED PROTECTIVE ORDER

CASE NO. 04-CV-05429 CW

10. Filing Documents Under Seal.

a. No items will be filed under seal without a prior application to, and order from, the 

judge presiding over the hearing or trial. Only when the judge presiding over the hearing or trial 

permits filing an item or items under seal may confidential material filed with the court be filed in 

a sealed envelope or other container, marked on the outside with the caption of this action and the 

following statement:

“CONFIDENTIAL - SUBJECT TO PROTECTIVE ORDER.”

If any person fails to file protected documents or information under seal, any party to this 

lawsuit may request that the court place the filing under seal.

b. The parties agree that if a filing includes Confidential Information of another party 

or third party, they shall file a request that such filing be kept under seal.

11. Party’s Own Information.

A party is free to do whatever it desires with its own Confidential Information and is not 

bound by this Stipulation and Protective Order with respect to the disclosure of its own 

Confidential Information.

12. Disclosure To Author Or Addressee.

Nothing herein shall prohibit a party, or its counsel, from disclosing a document which 

contains Confidential Information to the person who is an author, or is listed as an addressee or 

recipient of that document, or who had access to it while employed by one of the parties.

13. No Waiver.

Other than as specified herein, neither the taking of nor the failure to take any action to 

enforce the provisions of this Stipulation and Protective Order, nor the failure to object to any 

designation or any such action or omission, shall constitute a waiver of any right to seek and 

obtain protection or relief in this action or any other action including, but not limited to, the right 

to claim that any information is or is not proprietary to any party, is or is not entitled to particular 

protection or that such information does or does not embody trade secrets of any party. The 

procedure set forth herein shall not affect the rights of parties to object to discovery on grounds 

Case 4:04-cv-05429-CW Document 169 Filed 09/07/05 Page 11 of 22
M CDERMOTT 

WILL 

& EMERY LLP

ATTORNEYS AT LA W

PALO ALTO

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

MPK 92461-8.073241.0011 12 STIPULATED PROTECTIVE ORDER

CASE NO. 04-CV-05429 CW

other than those related to trade secrets or proprietary information claims, nor shall it relieve a 

party of the necessity of proper response to discovery devices.

14. No Probative Value.

This Stipulation and Protective Order shall not abrogate or diminish any contractual, 

statutory or other legal obligation or right of any party or person with respect to any Confidential 

Information. The fact that information is designated “Confidential Information” under this 

Stipulation and Protective Order shall not be deemed to be determinative of what a trier of fact 

may determine to be confidential or proprietary. This Stipulation and Protective Order shall be 

without prejudice to the right of any party to bring before the Court the question of: (a) whether 

any particular material is or is not confidential; (b) whether any particular information or material 

is or is not entitled to a greater or lesser degree of protection than provided hereunder; or (c) 

whether any particular information or material is or is not relevant to any issue of this case, 

provided that in doing so the party complies with the foregoing procedures. Absent a stipulation 

of all parties, the fact that information has been designated “CONFIDENTIAL” under this 

Stipulation and Protective Order shall not be admissible during the trial of this action, nor shall 

the jury be advised of such designation. The fact that any information is disclosed, used or 

produced in discovery or trial herein shall not be construed as admissible, or offered in any action 

or proceeding before any court, agency or tribunal as evidence of or concerning whether or not 

such information is confidential or proprietary.

15. Subpoena From Third Parties.

In the event any party or nonparty having possession, custody or control of any 

Confidential Information receives a subpoena or other process or order to produce such 

information, such party or nonparty shall notify the attorneys of record of the party or nonparty 

claiming such confidential treatment of the Confidential Information sought by such subpoena or 

other process or order, shall furnish those attorneys of record with a copy of said subpoena or 

other process or order, and shall cooperate with respect to any procedure sought to be pursued by 

the party or nonparty claiming such confidential treatment. The party or nonparty asserting the 

confidential treatment shall have the burden of defending against such subpoena, process or order. 

Case 4:04-cv-05429-CW Document 169 Filed 09/07/05 Page 12 of 22
M CDERMOTT 

WILL 

& EMERY LLP

ATTORNEYS AT LA W

PALO ALTO

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

MPK 92461-8.073241.0011 13 STIPULATED PROTECTIVE ORDER

CASE NO. 04-CV-05429 CW

The party or person receiving the subpoena or other process or order will not produce 

Confidential Information so long as any motion or proceeding initiated to bar disclosure is 

pending.

16. Inadvertent Production of Confidential Information.

In the event that Confidential Information designated by the Designating Party in 

accordance with paragraph 1, above, is disclosed by the disclosing party to any person other than 

the Qualified Persons defined in paragraph 5 above, or is disclosed in any manner or for any 

purpose inconsistent with the terms of this Stipulation and Protective Order, the party responsible 

for the disclosure, within five (5) days of Outside Counsel’s awareness of such disclosure, must 

bring all pertinent facts relating to such disclosure to the attention of the Outside Counsel for the 

Designating Party and without prejudice to the rights and remedies of the Designating Party, 

make every reasonable effort to prevent further disclosure of it and prevent further disclosure by 

each person who was the eventual recipient of the Confidential Information.

17. Inadvertent Production of Privileged Information.

Inadvertent production of documents or information subject to the attorney client privilege 

or work product immunity shall not constitute a waiver of such privilege. After receiving notice 

from the Designating Party that documents or information subject to the attorney client privilege 

or work product immunity have been inadvertently produced, the receiving party shall not review, 

copy or disseminate such documents or information. The receiving party shall return such 

documents or information to the Designating Party immediately.

18. Termination Of Litigation.

Within 90 days of receipt of written notice of the final disposition of the above-entitled 

case, whether by judgment and exhaustion of all appeals, by voluntary dismissal, or by 

settlement, Outside Counsel:

a. Shall return to the disclosing party, or its Outside Counsel, the Confidential 

Information in their possession, custody or control or in the possession, custody or control of their 

staff or shall destroy such information;

Case 4:04-cv-05429-CW Document 169 Filed 09/07/05 Page 13 of 22
M CDERMOTT 

WILL 

& EMERY LLP

ATTORNEYS AT LA W

PALO ALTO

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

MPK 92461-8.073241.0011 14 STIPULATED PROTECTIVE ORDER

CASE NO. 04-CV-05429 CW

b. Shall insure that all the Confidential Information in the possession, custody or 

control of their experts and consultants, is returned to the disclosing party, or its Outside Counsel, 

or is destroyed;

c. Shall destroy all notes, memoranda or other documents which contain excerpts 

from any of the Confidential Information provided;

d. Shall deliver to the disclosing party, or its Outside Counsel, an affidavit or 

declaration that there has been compliance with the terms of this paragraph or that there has not 

been compliance and the reason for such noncompliance, upon receipt of which the disclosing 

party may make application to the Court for such further order as may be appropriate.

e. Notwithstanding the terms of this section, each Outside Counsel may retain one 

copy of all pleadings, discovery and work product.

f. Notwithstanding the foregoing, no person having access to Confidential 

Information shall be involved with or participate in patenting pertaining to the subject matter of 

the patents in suit, during this litigation and for a period of one year following the termination of 

this litigation, including any appeals. For the purposes of this section, “patenting” shall mean:

(i) preparing and/or prosecuting any application (or portion thereof) relating to the 

subject matter of the patents in suit, whether design or utility, and either in the United States or 

abroad;

(ii) preparing patent claim(s) relating to the subject matter of the patents in suit; and

(iii) providing advice, counsel or suggestion regarding, or in any other way 

influencing, claim scope and/or language, embodiment(s) for claim coverage, claim(s) for 

prosecution, or products or processes for coverage by claim(s) relating to the subject matter of the 

patents in suit.

19. Enforcement Of This Stipulation And Protective Order.

This Stipulation and Protective Order shall survive the final conclusion of the action and 

the Court shall have jurisdiction to enforce this Stipulation and Protective Order beyond the 

conclusion of this action, unless this Stipulation and Protective Order is vacated.

Case 4:04-cv-05429-CW Document 169 Filed 09/07/05 Page 14 of 22
M CDERMOTT 

WILL 

& EMERY LLP

ATTORNEYS AT LA W

PALO ALTO

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

MPK 92461-8.073241.0011 15 STIPULATED PROTECTIVE ORDER

CASE NO. 04-CV-05429 CW

20. Modification Of This Stipulation and Protective Order.

In the event any party hereto seeks a court order that in any way seeks to vary the terms of 

this Stipulation and Protective Order, said party shall make such request in the form of a written 

stipulation, ex parte application, or noticed motion to all parties that must be served and filed in 

accordance with court rules.

21. Counsel Rendering Advice to Their Clients.

Nothing in this Stipulation and Protective Order shall prevent or otherwise restrict counsel 

from rendering advice to their clients and, in the course thereof, relying generally on material 

designated as “CONFIDENTIAL”; provided, however, that in rendering such advice counsel 

shall not disclose, reveal, or describe the content of any material so designated except insofar as 

allowed (if allowed at all) under the terms of this Stipulation and Protective Order.

August 29, 2005 MCDERMOTT WILL & EMERY LLP

By:

William G. Gaede, III

Attorneys for Tercica, Inc.

August 30, 2005 HELLER EHRMAN LLP

By:

M. Patricia Thayer

Attorneys for Genentech, Inc.

August 29, 2005 FOLEY & LARDNER LLP

By:

Larry L. Shatzer

Attorneys for Insmed Incorporated. & Celtrix 

Pharmaceuticals, Inc.

Case 4:04-cv-05429-CW Document 169 Filed 09/07/05 Page 15 of 22
M CDERMOTT 

WILL 

& EMERY LLP

ATTORNEYS AT LA W

PALO ALTO

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

MPK 92461-8.073241.0011 16 STIPULATED PROTECTIVE ORDER

CASE NO. 04-CV-05429 CW

PURSUANT TO STIPULATION, IT IS SO ORDERED, BUT SEE LOCAL RULE 79-

5.

9/7/05 /s/ CLAUDIA WILKEN

DATED:

Honorable Claudia Wilkin

United States District Court Judge

Case 4:04-cv-05429-CW Document 169 Filed 09/07/05 Page 16 of 22
M CDERMOTT 

WILL 

& EMERY LLP

ATTORNEYS AT LA W

PALO ALTO

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

MPK 92461-8.073241.0011 17 STIPULATED PROTECTIVE ORDER

CASE NO. 04-CV-05429 CW

UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF CALIFORNIA

GENENTECH, INC., a Delaware 

Corporation, TERCICA, INC., a Delaware 

Corporation,

Plaintiffs,

v.

INSMED INCORPORATED, a Virginia 

Corporation, CELTRIX 

PHARMACEUTICALS, INC., a Delaware 

corporation,

Defendants.

No. 04-CV-05429-CW

AFFIDAVITREGARDINGRECEIPT OF

CONFIDENTIALINFORMATION

ATTACHMENT A

I, _________________________________________, declare that:

1. A copy of my most recent curriculum vitae is attached hereto.

2. My office address is___________________________________, and my present

employer is __________________________________________________________________.

3. My present occupation or job description is ______________________________.

4. For the past ten years, my employment history has been:

_____________________________________________________________________________

_____________________________________________________________________________

_____________________________________________________________________________

5. I have received a copy of the Protective Order Re Confidential Information (the 

“Protective Order”) in this action.

Case 4:04-cv-05429-CW Document 169 Filed 09/07/05 Page 17 of 22
M CDERMOTT 

WILL 

& EMERY LLP

ATTORNEYS AT LA W

PALO ALTO

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

MPK 92461-8.073241.0011 18 STIPULATED PROTECTIVE ORDER

CASE NO. 04-CV-05429 CW

6. I have carefully read and understand the provisions of the Protective Order, agree 

to be bound by it, and specifically agree I will not use or disclose to anyone any of the contents of 

any Confidential Information received under the protection of the Protective Order.

7. I understand that I am to retain all copies of any of the materials that I receive 

which have been so designated as Confidential Information in a container, cabinet, drawer, room 

or other safe place in a manner consistent with the Protective Order and that all copies are to 

remain in my custody until I have completed my assigned or legal duties. I will return all 

confidential documents and things which come into my possession or which I have prepared 

relating thereto, to counsel for the party by whom I am retained. I acknowledge that such return 

or the subsequent destruction of such materials shall not relieve me from any of the continuing 

obligations imposed upon me by the Protective Order.

I declare under penalty of perjury under the laws of the State of California that the 

foregoing is true and correct.

Executed this _______ day of ______________________, 200_, at ___________, in the 

State of _________________________.

____________________________________

[SIGNATURE]

Case 4:04-cv-05429-CW Document 169 Filed 09/07/05 Page 18 of 22
M CDERMOTT 

WILL 

& EMERY LLP

ATTORNEYS AT LA W

PALO ALTO

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

MPK 92461-8.073241.0011 19 STIPULATED PROTECTIVE ORDER

CASE NO. 04-CV-05429 CW

ATTACHMENT B

SELECTED SECTIONS FROM INSMED’S NDA FOR 

DISCLOSURE TO IN-HOUSE COUNSEL

MODULE I ADMINISTRATION & PRESCRIBING INFORMATION

1.5 SECTION TITLE OMITTED

1.9 SECTION TITLE OMITTED

1.10 SECTION TITLE OMITTED

1.10.1 SECTION TITLE OMITTED

1.12 SECTION TITLE OMITTED

MODULE 2 SUMMARIES AND REVIEW (All) 

2.1 SECTION TITLE OMITTED

2.2 SECTION TITLE OMITTED

2.3 SECTION TITLE OMITTED

2.4 SECTION TITLE OMITTED

2.5 SECTION TITLE OMITTED

2.6 SECTION TITLE OMITTED

2.7 SECTION TITLE OMITTED

MODULE 3 INFORMATION AND PRODUCT QUALITY - CMC

3.1 SECTION TITLE OMITTED

3.2 SECTION TITLE OMITTED

3.2.S SECTION TITLE OMITTED

3.2.S.1 SECTION TITLE OMITTED

3.2.S.1.1 SECTION TITLE OMITTED

3.2.S.1.2. SECTION TITLE OMITTED

3.2.S.1.3. SECTION TITLE OMITTED

Case 4:04-cv-05429-CW Document 169 Filed 09/07/05 Page 19 of 22
M CDERMOTT 

WILL 

& EMERY LLP

ATTORNEYS AT LA W

PALO ALTO

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

MPK 92461-8.073241.0011 20 STIPULATED PROTECTIVE ORDER

CASE NO. 04-CV-05429 CW

3.2.S.2. SECTION TITLE OMITTED

3.2.S.2.1 SECTION TITLE OMITTED

3.2.S.2.2 SECTION TITLE OMITTED

3.2.S.2.6 SECTION TITLE OMITTED

3.2.S.3. SECTION TITLE OMITTED

3.2.S.3.1 SECTION TITLE OMITTED

3.2.S.3.2 SECTION TITLE OMITTED

3.2.S.4. SECTION TITLE OMITTED

3.2.S.4.1 SECTION TITLE OMITTED

3.2.P SECTION TITLE OMITTED

3.2.P.1. SECTION TITLE OMITTED

3.2.P.2. SECTION TITLE OMITTED

3.2.P.3. SECTION TITLE OMITTED

3.2.P.3.1 SECTION TITLE OMITTED

3.2.P.3.2 SECTION TITLE OMITTED

3.2.P.3.3 SECTION TITLE OMITTED

3.2.P.5. SECTION TITLE OMITTED t

3.2.P.5.1 SECTION TITLE OMITTED

3.2.R SECTION TITLE OMITTED

4.2.1 SECTION TITLE OMITTED

4.2.1.1 SECTION TITLE OMITTED

4.2.1.1.a SECTION TITLE OMITTED

4.2.1.1.a.1. SECTION TITLE OMITTED

4.2.1.1.a.2. SECTION TITLE OMITTED

4.2.1.1.a.3. SECTION TITLE OMITTED

4.2.1.1.a.4. SECTION TITLE OMITTED

Case 4:04-cv-05429-CW Document 169 Filed 09/07/05 Page 20 of 22
M CDERMOTT 

WILL 

& EMERY LLP

ATTORNEYS AT LA W

PALO ALTO

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

MPK 92461-8.073241.0011 21 STIPULATED PROTECTIVE ORDER

CASE NO. 04-CV-05429 CW

4.2.1.1.a.5. SECTION TITLE OMITTED

4.2.1.2.b SECTION TITLE OMITTED

4.2.2.2.a SECTION TITLE OMITTED

4.2.2.2.b.2 SECTION TITLE OMITTED

4.2.2.2.b.3 SECTION TITLE OMITTED

4.2.2.2.b.4 SECTION TITLE OMITTED

4.2.3.1.a SECTION TITLE OMITTED

4.2.3.1.b.1 SECTION TITLE OMITTED

4.2.3.2.a SECTION TITLE OMITTED

4.2.3.2.b SECTION TITLE OMITTED

4.2.3.2.b.1 SECTION TITLE OMITTED

4.2.3.2.b.2 SECTION TITLE OMITTED

4.2.3.2.b.3 SECTION TITLE OMITTED

4.2.3.2.b.4 SECTION TITLE OMITTED

4.2.3.2.b.9 SECTION TITLE OMITTED

4.2.3.2.b.10 SECTION TITLE OMITTED

MODULE 5 CLINICAL STUDY REPORTS

5.1 SECTION TITLE OMITTED

5.2 SECTION TITLE OMITTED

5.3 SECTION TITLE OMITTED

5.3.1 SECTION TITLE OMITTED

5.3.1.1 SECTION TITLE OMITTED

5.3.1.2 SECTION TITLE OMITTED

5.3.1.2.1 SECTION TITLE OMITTED

5.3.1.3 SECTION TITLE OMITTED

5.3.2 SECTION TITLE OMITTED

Case 4:04-cv-05429-CW Document 169 Filed 09/07/05 Page 21 of 22
M CDERMOTT 

WILL 

& EMERY LLP

ATTORNEYS AT LA W

PALO ALTO

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

MPK 92461-8.073241.0011 22 STIPULATED PROTECTIVE ORDER

CASE NO. 04-CV-05429 CW

5.3.3 SECTION TITLE OMITTED

5.3.4 SECTION TITLE OMITTED

5.3.5 SECTION TITLE OMITTED

5.3.7 SECTION TITLE OMITTED

5.4 SECTION TITLE OMITTED

Case 4:04-cv-05429-CW Document 169 Filed 09/07/05 Page 22 of 22